Growth Metrics

Scholar Rock Holding (SRRK) Equity Average (2018 - 2026)

Scholar Rock Holding's quarterly Equity Average came in at $260.8 million in Q1 2026, down 23.42% year-on-year from $340.5 million in Q1 2025, and up 6.32% quarter-over-quarter from $245.2 million in Q4 2025.

Scholar Rock Holding has reported Equity Average for 9 years, with the latest figure at $260.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Equity Average fell 23.42% year-over-year to $260.8 million; the trailing twelve-month figure through Mar 2026 stood at $260.8 million (down 23.42% YoY), and the FY2025 full-year result was $307.1 million, up 3.41% from the prior year.
  • Equity Average for Q1 2026 stood at $260.8 million, up from $245.2 million in the prior quarter.
  • The five-year high for Equity Average was $340.5 million in Q1 2025, with the low at $106.4 million in Q3 2024.
  • Average Equity Average over 5 years is $229.6 million, with a median of $239.1 million recorded in 2025.
  • Year-over-year, Equity Average tumbled 42.51% in 2024 and jumped 124.74% in 2025.
  • Tracing SRRK's Equity Average over 5 years: stood at $276.8 million in 2022, then dropped by 29.02% to $196.4 million in 2023, then climbed by 13.99% to $223.9 million in 2024, then rose by 9.52% to $245.2 million in 2025, then advanced by 6.32% to $260.8 million in 2026.
  • The last three Equity Average figures came in at $260.8 million (Q1 2026), $245.2 million (Q4 2025), and $239.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Avg. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 3.76 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 21.35 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 19.01 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 31.34 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 932.28 Mn
10 Scholar Rock Holding 500.61 Mn 20.67 Mn - 260.75 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 260.75 Mn
Dec 31, 2025 245.24 Mn
Sep 30, 2025 239.14 Mn
Jun 30, 2025 272.81 Mn
Mar 31, 2025 340.48 Mn
Dec 31, 2024 223.92 Mn
Sep 30, 2024 106.41 Mn
Jun 30, 2024 158.20 Mn
Mar 31, 2024 204.00 Mn
Dec 31, 2023 196.44 Mn
Sep 30, 2023 185.08 Mn
Jun 30, 2023 215.58 Mn
Mar 31, 2023 244.44 Mn
Dec 31, 2022 276.75 Mn
Sep 30, 2022 311.39 Mn
Jun 30, 2022 250.41 Mn
Mar 31, 2022 171.70 Mn
Dec 31, 2021 179.67 Mn
Sep 30, 2021 201.96 Mn
Jun 30, 2021 228.60 Mn
Mar 31, 2021 250.66 Mn
Dec 31, 2020 161.87 Mn
Sep 30, 2020 72.58 Mn
Jun 30, 2020 90.41 Mn
Mar 31, 2020 105.77 Mn
Dec 31, 2019 117.35 Mn
Sep 30, 2019 125.37 Mn
Jun 30, 2019 113.24 Mn
Mar 31, 2019 102.07 Mn
Dec 31, 2018 104.48 Mn
Sep 30, 2018 106.98 Mn
Jun 30, 2018 24.84 Mn
Mar 31, 2018 -57.73 Mn